Here, our analyses showed that COL5A2 expression was higher in the high-risk group, and increased COL5A2 expression indicated a worse prognosis in osteosarcoma patients, suggesting a potential oncogenic role in osteosarcoma. This evidence concerns the gene COL5A2 and osteosarcoma.